← All trials
NCT04711980
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2021
- Primary completion
- Feb 28, 2022
- Completion date
- Sep 30, 2022
- First posted
- Jan 15, 2021
- Last posted
- Jan 15, 2021
- Enrollment
- 402
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- China Academy of Chinese Medical SciencesLead sponsor
- China Academy of Chinese Medical SciencesSponsor investigator
- Liaoning Hospital of Traditional Chinese MedicineOverall official - principal investigator
- Liaoning Hospital of Traditional Chinese MedicineCollaborator
- Chinese Academy of Medical SciencesOverall official - principal investigator
- Chinese Academy of Medical SciencesCollaborator
- Fudan UniversityOverall official - principal investigator
- Fudan UniversityCollaborator
- Peking UniversityOverall official - principal investigator
- Peking UniversityCollaborator
- Chengdu University of Traditional Chinese MedicinesOverall official - principal investigator
- Chengdu University of Traditional Chinese MedicinesCollaborator
- Changchun University of Chinese MedicineOverall official - principal investigator
- Changchun University of Chinese MedicineCollaborator
- Qingdao UniversityOverall official - principal investigator
- Qingdao UniversityCollaborator
- Tianjin Medical UniversityOverall official - principal investigator
- Tianjin Medical UniversityCollaborator
- Henan Medical UniversityOverall official - principal investigator
- Henan Medical UniversityCollaborator
- Gansu Provincial HospitalOverall official - principal investigator
- Gansu Provincial HospitalCollaborator
- The Third Hospital of Xi'anOverall official - principal investigator
- The Third Hospital of Xi'anCollaborator
- The Fourth People's Hospital of ChongqingOverall official - principal investigator
- The Fourth People's Hospital of ChongqingCollaborator
- Guangzhou University of Traditional Chinese MedicineOverall official - principal investigator
- Guangzhou University of Traditional Chinese MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.